
Elimination of a cholecystokinin receptor agonist ‘trigger’ in an effort to develop positive allosteric modulators without intrinsic agonist activity
Keywords: مدولاتور آلوده کننده مثبت; BDZ, benzodiazepine; CCK, cholecystokinin; CCK1R, type 1 cholecystokinin receptor; PAM, positive allosteric modulator; TM, transmembraneCholecystokinin; CCK1R; G protein-coupled receptors; Positive allosteric modulator; Obesity